FibroGen, Inc. (NASDAQ:FGEN) Q4 2023 Earnings Call Transcript February 26, 2024
FibroGen, Inc. misses on earnings expectations. Reported EPS is $-0.57 EPS, expectations were $-0.42. FibroGen, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Thank you for standing by and welcome to FibroGen’s Fourth Quarter and Full Year 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today’s call...
